HIGHLIGHTS
- who: Tianqing Sang and collaborators from the The First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, Henan Province, China have published the Article: Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Bushen Hugu Decoction in the Treatment of Malignant Tumor Bone Metastases, in the Journal: BioMed Research International
- what: The authors used network pharmacology technology to investigate the potential mechanism of BHD on bone metastases and molecular docking technology to screen the major effective components and targets for BHD.
- how: The molecular docking results showed that the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.